Vor Biopharma (VOR)
US Market

Vor Biopharma (VOR) Cash flow


Vor Biopharma Cash Flow

VOR's free cash flow for Q3 2023 was $―. For the 2023 fiscal year, VOR's free cash flow was decreased by $-20.53M and operating cash flow was $-27.90M. See a summary of the company’s cash flow.
Cash Flow
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -94.62M$ -85.14M$ -69.18M$ -36.29M$ -9.86M$ -2.66M
Investing Cash Flow
$ -36.36M$ -94.09M$ -91.65M$ -4.16M$ -748.00K$ 0.00
Financing Cash Flow
$ 115.17M$ 117.14M$ 232.91M$ 82.53M$ 17.70M$ 2.46M
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 186.97M$ 60.09M$ 122.18M$ 50.10M$ 8.03M$ 929.00K
Income Tax Paid Supplemental Data
Interest Paid Supplemental Data
Issuance Of Capital Stock
$ 4.70M$ 4.45M$ 189.20M$ 82.27M$ 17.69M$ 0.00
Issuance Of Debt
----$ 0.00$ 2.46M
Repayment Of Debt
Free Cash Flow
$ -67.53M$ -93.61M$ -73.07M$ -40.45M$ -10.60M$ -2.66M
Domestic Sales
Foreign Sales
Currency in USD

Vor Biopharma Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis